Literature DB >> 2015237

Firstborn adolescent daughters and mothers with and without premenstrual syndrome: a comparison.

C A Wilson1, C W Turner, W R Keye.   

Abstract

Firstborn adolescent daughters and their mothers with and without premenstrual syndrome (PMS) were evaluated for two menstrual cycles in order to compare menstrual, postmenstrual (follicular), and premenstrual (luteal) symptomatology. Physical and psychological symptoms were evaluated according to the Premenstrual Assessment Form (PAF) and the Utah PMS Calendar II. The onset of the luteal phase was defined as the day of the midcycle surge of luteinizing hormone (LH), determined by utilizing the CUE Ovulation Predictor. The PAF showed that 1) irrespective of diagnosis, severity of symptoms was not significantly different between adolescents and adults; however, 2) when daughters and mothers were grouped according to mother's diagnosis, the PMS mother/daughter dyads experienced significantly more premenstrual symptoms when compared to the non-PMS mother/daughter dyads. Furthermore, the PMS Calendar revealed menstrual cycle phase delineation. There were no significant differences in severity of symptoms between adults and adolescents during the postmenstrual (follicular) phase and the premenstrual (luteal) phase. However, the adolescents experienced significantly more symptoms during the menstrual phase than the adults. 1) There were no significant differences in severity of adolescents' menstrual symptoms and their premenstrual (luteal) symptoms; 2) the number and severity of luteal phase symptoms were significantly greater for the women with PMS and their daughters than women without PMS and their daughters.

Entities:  

Mesh:

Year:  1991        PMID: 2015237     DOI: 10.1016/0197-0070(91)90455-u

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  7 in total

1.  Estrogen receptor alpha (ESR-1) associations with psychological traits in women with PMDD and controls.

Authors:  Alexandra Miller; Hoa Vo; Liang Huo; Catherine Roca; Peter J Schmidt; David R Rubinow
Journal:  J Psychiatr Res       Date:  2010-02-20       Impact factor: 4.791

Review 2.  Premenstrual syndrome. Identification and management.

Authors:  S K Severino; M L Moline
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

3.  Variant brain-derived neurotrophic factor (Valine66Methionine) polymorphism contributes to developmental and estrous stage-specific expression of anxiety-like behavior in female mice.

Authors:  Kevin G Bath; Jocelyn Chuang; Joanna L Spencer-Segal; Dima Amso; Margaret Altemus; Bruce S McEwen; Francis S Lee
Journal:  Biol Psychiatry       Date:  2012-05-01       Impact factor: 13.382

Review 4.  Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.

Authors:  Andrea J Rapkin; Judith A Mikacich
Journal:  Paediatr Drugs       Date:  2013-06       Impact factor: 3.022

5.  Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene.

Authors:  Liang Huo; Richard E Straub; Catherine Roca; Peter J Schmidt; Kai Shi; Radhakrishna Vakkalanka; Daniel R Weinberger; David R Rubinow
Journal:  Biol Psychiatry       Date:  2007-06-27       Impact factor: 13.382

Review 6.  Sex differences in anxiety and depression clinical perspectives.

Authors:  Margaret Altemus; Nilofar Sarvaiya; C Neill Epperson
Journal:  Front Neuroendocrinol       Date:  2014-06-02       Impact factor: 8.606

7.  Lack of association of DRD3 and CNR1 polymorphisms with premenstrual dysphoric disorders.

Authors:  Mesut Yıldız; Mehmet Vural; Mehmet Emin Erdal; Özlem İzci Ay; Şenay Görücü Yılmaz; İbrahim Fatih Karababa; Salih Selek
Journal:  Iran J Reprod Med       Date:  2015-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.